Michael Gottlieb
Corporate Officer/Principal at POINT Biopharma, Inc. (United States)
Profile
Michael Gottlieb is currently the Chief Commercial Officer at POINT Biopharma, Inc. in the United States.
Prior to this, he worked at Sanofi Canada, Inc. as the Head of Rare Diseases Franchise from 2017 to 2019.
He also briefly served as the Chief Commercial Officer at POINT Biopharma Global, Inc. in 2021.
Mr. Gottlieb has a graduate degree from the University of Toronto and an undergraduate degree from the University of Western Ontario.
Michael Gottlieb active positions
| Companies | Position | Start |
|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | 2019-12-31 |
Former positions of Michael Gottlieb
| Companies | Position | End |
|---|---|---|
| POIT BIOP | Corporate Officer/Principal | 2021-11-24 |
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Corporate Officer/Principal | 2019-08-31 |
Training of Michael Gottlieb
| University of Western Ontario | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Private companies | 2 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
- Stock Market
- Insiders
- Michael Gottlieb
